Varant Kupelian
Overview
Explore the profile of Varant Kupelian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
3457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goutman S, Goyal N, Payne K, Paisan-Ruiz C, Kupelian V, Kang M, et al.
Ann Clin Transl Neurol
. 2024 Jul;
11(8):2201-2211.
PMID: 39044379
Objective: To report initial results from the Amyotrophic Lateral Sclerosis (ALS) Identified genetic testing (GT) program on characteristics of individuals tested and frequency of reported disease-causing variants. Methods: ALS Identified...
2.
Barberio J, Lally C, Kupelian V, Hardiman O, Flanders W
Neurol Genet
. 2023 Dec;
9(6):e200109.
PMID: 38045991
Background And Objectives: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder. Familial (fALS) cases are usually reported to constitute 5%-10% of all ALS cases; however, no recent literature review...
3.
Kupelian V, Viscidi E, Hall S, Li L, Eaton S, Dilley A, et al.
Neurol Clin Pract
. 2023 Mar;
13(1):e200110.
PMID: 36891280
Background And Objectives: Reduced mobility in patients with amyotrophic lateral sclerosis (ALS) is hypothesized to increase the risk of venous thromboembolism (VTE). A few small, single-center studies have investigated the...
4.
Moller R, Zhao L, Shoaff J, Duno M, Andersen B, Nguyen V, et al.
Mol Genet Metab Rep
. 2022 Oct;
33:100924.
PMID: 36262748
Objective: To estimate the incidence of Aicardi-Goutières syndrome (AGS) and potassium sodium-activated channel subfamily T member 1 (-related epilepsy in Denmark and to characterize the patients diagnosed with AGS and...
5.
Viscidi E, Juneja M, Wang J, Wang N, Li L, Farwell W, et al.
Neurol Ther
. 2022 May;
11(2):929-930.
PMID: 35507289
No abstract available.
6.
Viscidi E, Juneja M, Wang J, Wang N, Li L, Farwell W, et al.
Neurol Ther
. 2021 Dec;
11(1):449-457.
PMID: 34936050
Introduction: There is little information about survival of spinal muscular atrophy (SMA) patients into adulthood, in particular from population-based samples. We estimated and compared age-specific, all-cause mortality rates in patients...
7.
Brown C, Lally C, Kupelian V, Flanders W
Neuroepidemiology
. 2021 Jul;
55(5):342-353.
PMID: 34247168
Introduction: Amyotrophic lateral sclerosis (ALS) is a rare neurological disorder characterized by progressive deterioration of motor neurons. Assessment of the size/geographic distribution of the ALS population, including ALS with genetic...
8.
Rist P, Kupelian V, Petrillo M, Sohn J, Farwell W, Sesso H
J Neuromuscul Dis
. 2021 Feb;
8(4):621-624.
PMID: 33612493
Little is known about the feasibility of using long-term stored blood samples to measure neurofilament levels and about long-term changes in neurofilament levels among healthy individuals. We performed a pilot...
9.
Schaefer F, Ardissino G, Ariceta G, Fakhouri F, Scully M, Isbel N, et al.
Kidney Int
. 2018 Jun;
94(2):408-418.
PMID: 29907460
Atypical hemolytic uremic syndrome (aHUS) is a rare, genetic, life-threatening disease. The Global aHUS Registry collects real-world data on the natural history of the disease. Here we characterize end-stage renal...
10.
Tinsley L, Kupelian V, DEon S, Pober D, Sun J, King G, et al.
J Clin Endocrinol Metab
. 2017 Oct;
102(10):3704-3711.
PMID: 28973526
Context: Previously we demonstrated, in individuals who have had type 1 diabetes (T1D) for 50 or more years (Medalists), that glycemic control was unrelated to diabetic complications, with the exception...